VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,241 | -34.4% | 3,065 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $20,198 | +71.0% | 3,065 | +76.1% | 0.00% | 0.0% |
Q1 2023 | $11,815 | -55.4% | 1,740 | -51.5% | 0.00% | 0.0% |
Q4 2022 | $26,515 | -25.2% | 3,588 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $35,449 | -9.4% | 3,588 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $39,109 | -3.6% | 3,588 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $40,580 | -82.5% | 3,588 | -75.8% | 0.00% | -66.7% |
Q4 2021 | $232,290 | +1.0% | 14,805 | +10.3% | 0.00% | 0.0% |
Q3 2021 | $230,002 | -34.4% | 13,419 | -17.7% | 0.00% | -40.0% |
Q2 2021 | $350,591 | +59.3% | 16,299 | +11.2% | 0.01% | +66.7% |
Q1 2021 | $220,058 | +33.7% | 14,651 | +16.9% | 0.00% | +50.0% |
Q4 2020 | $164,631 | +0.3% | 12,529 | -26.3% | 0.00% | -33.3% |
Q3 2020 | $164,162 | -15.6% | 16,994 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $194,411 | +10.4% | 16,994 | 0.0% | 0.00% | -25.0% |
Q1 2020 | $176,058 | -34.3% | 16,994 | +4.1% | 0.00% | 0.0% |
Q4 2019 | $267,975 | +17.4% | 16,330 | -5.0% | 0.00% | 0.0% |
Q3 2019 | $228,243 | -5.7% | 17,187 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $242,165 | -23.4% | 17,187 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $316,241 | -29.6% | 17,187 | 0.0% | 0.01% | -33.3% |
Q4 2018 | $449,096 | +13.9% | 17,187 | 0.0% | 0.01% | +28.6% |
Q3 2018 | $394,442 | -99.9% | 17,187 | 0.0% | 0.01% | +40.0% |
Q2 2018 | $327,412,000 | +33.9% | 17,187 | +18.4% | 0.01% | +66.7% |
Q1 2018 | $244,594,000 | +110576.0% | 14,516 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $221,000 | -54.2% | 14,516 | -51.0% | 0.00% | 0.0% |
Q2 2017 | $483,000 | +16.7% | 29,606 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $414,000 | -12.3% | 29,606 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $472,000 | -4.3% | 29,606 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $493,000 | +48.9% | 29,606 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $331,000 | +33.5% | 29,606 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $248,000 | -10.1% | 29,606 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $276,000 | -17.4% | 29,606 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $334,000 | -11.2% | 29,606 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $376,000 | +27.0% | 29,606 | -7.0% | 0.00% | +50.0% |
Q1 2015 | $296,000 | -35.1% | 31,839 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $456,000 | +74.0% | 31,839 | +25.9% | 0.00% | +50.0% |
Q3 2014 | $262,000 | -35.9% | 25,280 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $409,000 | -0.5% | 25,280 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $411,000 | +30.9% | 25,280 | 0.0% | 0.00% | +50.0% |
Q4 2013 | $314,000 | +13.4% | 25,280 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $277,000 | +35.8% | 25,280 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $204,000 | – | 25,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |